ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · Real-Time Price · USD
142.51
+0.16 (0.11%)
Dec 5, 2025, 4:00 PM EST - Market closed
ICU Medical Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for ICU Medical stock have an average target of 183.6, with a low estimate of 172 and a high estimate of 200. The average target predicts an increase of 28.83% from the current stock price of 142.51.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ICU Medical stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Keybanc | Keybanc | Buy Maintains $173 → $175 | Buy | Maintains | $173 → $175 | +22.80% | Nov 7, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $153 → $172 | Buy | Maintains | $153 → $172 | +20.69% | Nov 7, 2025 |
| Keybanc | Keybanc | Buy Maintains $191 → $173 | Buy | Maintains | $191 → $173 | +21.39% | Oct 21, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $145 → $153 | Buy | Maintains | $145 → $153 | +7.36% | Sep 10, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $145 | Buy | Initiates | $145 | +1.75% | Aug 15, 2025 |
Financial Forecast
Revenue This Year
2.26B
from 2.38B
Decreased by -5.21%
Revenue Next Year
2.22B
from 2.26B
Decreased by -1.55%
EPS This Year
7.71
from -4.83
EPS Next Year
8.20
from 7.71
Increased by 6.42%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.4B | 2.4B | |||
| Avg | 2.3B | 2.2B | |||
| Low | 2.2B | 2.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.9% | 7.0% | |||
| Avg | -5.2% | -1.6% | |||
| Low | -9.4% | -7.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.03 | 8.66 | |||
| Avg | 7.71 | 8.20 | |||
| Low | 7.33 | 7.77 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 12.4% | |||
| Avg | - | 6.4% | |||
| Low | - | 0.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.